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Abstract
Background: There is reason to expect strong genetic influences on the risk of developing active pulmonary
tuberculosis (TB) among latently infected individuals. Many of the genome wide linkage and association studies
(GWAS) to date have been conducted on African populations. In order to identify additional targets in genetically
dissimilar populations, and to enhance our understanding of this disease, we performed a multi-stage GWAS in a
Southeast Asian cohort from Indonesia.
Methods: In stage 1, we used the Affymetrix 100 K SNP GeneChip marker set to genotype 259 Indonesian
samples. After quality control filtering, 108 cases and 115 controls were analyzed for association of 95,207 SNPs. In
stage 2, we attempted validation of 2,453 SNPs with promising associations from the first stage, in 1,189 individuals
from the same Indonesian cohort, and finally in stage 3 we selected 251 SNPs from this stage to test TB
association in an independent Caucasian cohort (n = 3,760) from Russia.
Results: Our study suggests evidence of association (P = 0.0004-0.0067) for 8 independent loci (nominal
significance P < 0.05), which are located within or near the following genes involved in immune signaling: JAG1,
DYNLRB2, EBF1, TMEFF2, CCL17, HAUS6, PENK and TXNDC4.
Conclusions: Mechanisms of immune defense suggested by some of the identified genes exhibit biological
plausibility and may suggest novel pathways involved in the host containment of infection with TB.
Background
Tuberculosis (TB) remains one of the leading causes of
infection-associated mortality, with close to 10 million
new cases and 2 million deaths annually [1,2]. Although
Mycobacterium tuberculosis has infected around a third
of the world’s population, only 3-10% of those infected
develop active disease during their lifetime [3]. More
than 90% of infected individuals remain asymptomatic
with a latent infection. This indicates that host immune/
defense pathways are often highly effective in controlling
this disease. Because the infection causes such a burden
of disease in those unable to contain the infection, it is
important to discover underlying mechanisms to aid the
development of more effective interventions such as
better vaccines and novel treatments for latent and active
infection. Similarly, it is important to identify predictive
biomarkers that might identify individuals who are most
susceptible to developing active TB disease.
Studies of heritability using twins and other familial
designs have convincingly implicated a genetic component
contributing to outcomes of TB infection [4-7]. This has
encouraged us to conduct a genome-wide search for genes
relevant to pulmonary TB susceptibility and active disease.
Although animal and other models of infection have
implicated a small number of possible candidate genes,
these often have ambiguous or disappointing patterns of
replication in humans [8]. Furthermore, the testing of can-
didate gene hypotheses are severely limited by assump-
tions and limitations to our current knowledge of the
relevant pathways of immune containment. A genome
wide association study (GWAS), by contrast, can scan
nearly the entire genome for variants associated with a
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phenotype, free from limiting hypotheses of biological
plausibility. This innovation in the study of complex dis-
ease genetics in humans has proved successful in discover-
ing novel genetic associations across a wide array of
phenotypes and diseases [9,10]. In the case of TB, a
GWAS on African populations has identified a susceptibil-
ity locus for TB at chromosome 18 q11.2 [10]. The variant
implicated, rs4331426, lies within a gene-desert, with the
risk allele relatively common in the African population
studied, though it is found at much lower frequencies in
other populations, making it difficult to replicate the
reported association outside Africa [10].
In the current study, we embarked on a two-stage
GWAS using the first generation Affymetrix 100 K SNP
GeneChip marker set in an Indonesian population sam-
ple from Jakarta and Bandung, two cities on the island of
Java (n = 1,448) [11]. In stage 1, we analyzed 95,207 SNPs
of 108 cases and 115 controls, and synthesized 2,453
selected top SNPs (P < 0.05) on two Illumina GoldenGate
customized arrays, for genotyping the remaining 1,189
independent Indonesian samples, as validation in the sec-
ond stage. 251 promising SNPs (Indonesian 2 stages P <
0.05) from the initial Indonesian studies were subse-
quently selected for genotyping and testing TB associa-
tion in an independent cohort from Russia (n = 3,760).
We have detected several variants within or near genes
involved in immunity, albeit with nominal significance.
Nevertheless, the plausibility of biological mechanisms
suggested by some of these immune genes encourages us
to suggest these variants and genes for further study.
Methods
Subjects
Indonesian cohort
Indonesian TB patients and controls were enrolled from
the cities of Jakarta and Bandung on the island of Java,
Indonesia using a uniform enrollment protocol for all
subjects [12]. 799 TB patients (mean age 32, range 14-75,
55.8% male, see Table 1) had been diagnosed by the local
health care service using information about clinical
symptoms, chest X-rays, and sputum smear. For all cases
in this study, diagnosis was further confirmed by sputum
culture of M. tuberculosis. Clinical information, as well as
the patients’ age, ethnicity, socio-economic status, and
concurrent medical history were recorded in structured
questionnaires. Patients with extra-pulmonary TB, dia-
betes mellitus (fasting blood glucose > 126 mg/dL), and
HIV-positive subjects were excluded from the genetic
study [13,14]. 746 sex- and age (+/- 10 year) matched
control subjects from the same areas (mean age 33, range
15-70, 52.5% male), with no history of TB and showing
no evidence of TB-related infiltrates in chest X-rays were
enrolled from the same and neighboring households of
the enrolled cases. First-degree related individuals among
subjects were identified by genetics, and were excluded
from further analysis.
Self and parental ethnicities recorded during recruit-
ment were used to characterize subjects with a Javanese
origin from three groups -the Jawa, Betawi, and Sunda,
which altogether comprised more than 80% of the total
sample. Individuals in the non-Javanese category have
both parents coming from other Indonesian Islands,
whereas subjects with one parent from non-Javanese ori-
gin were considered having mixed parentage (Table 1).
Population outliers were detected by genetics in stage 1
using the genome wide markers (n = 95,207 SNPs), and
were excluded for further analysis. Subjects with self-
reported ethnicity that were of non-Indonesian origin
were excluded from stage 2 genotyping. This protocol
was reviewed and approved by the relevant institutional
review boards in Indonesia and the Netherlands.
Russian cohort
Russian TB patients and controls were collected at two
cities, St. Petersburg (1,528 patients and 1,609 controls)
and Samara (384 patients and 495 controls), using a uni-
form enrollment protocol for all samples, which has been
described previously [15]. In summary (Table 1), 1,912 TB
patients (mean age 43.8, range 17-86, 73.8% male) were
confirmed as cases by sputum culture of M. tuberculosis.
Patients with extra-pulmonary TB or HIV-positive were
Table 1 Demographic data of the study populations
Indonesian cohort Russian cohort
TB Patients
(n = 799)
Controls
(n = 746)
TB Patients
(n = 1,912)
Controls
(n = 2,104)
Age years (mean) 14-75 (32) 15-70 (33) 17-86 (44) 16-66 (30)
Gender male:female (%) 55.8% : 44.2% 52.5% : 47.5% 73.8% : 26.2% 75% : 25%
Self reported ethnicity (%)
Caucasian 0 0 1912 (100%) 2104 (100%)
Javanese 675 (84.48%) 617 (82.71%)
mixed (either parent Javanese) 26 (3.25%) 43 (5.76%)
non-Javanese 59 (7.38%) 32 (4.29%)
Unknown 39 (4.88%) 54 (7.24%)
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excluded from the genetic study. 2,104 (mean age 30,
range 16-66, 75.0% male) local blood bank donors with no
known history of TB were recruited as controls. Permis-
sions were obtained from the local ethics committees in
St. Petersburg and Samara, Russia, and Cambridge, UK,
and had written informed consent from all participating
subjects.
Genotyping
Stage 1: GWAS in Indonesian cohort
For the initial genome-wide scan, 125 cases and 134
controls were genotyped for 116,204 SNPs with the
Affymetrix 100 K Human mapping SNP set, according
to the manufacturer’s protocol. Genotype calling was
performed using Affymetrix’s BRLMM software [16].
For quality control purposes, subjects were excluded
based on: call-rate <90% (n = 2), first-degree familial rela-
tionship (n = 7), discrepancies with reported gender (n =
4), population outliers in an analysis of the first two princi-
pal components (n = 4) (see Additional file 1, Supplemen-
tary Figure S1), and a diagnosis of diabetes mellitus (n =
19), which has been consistently identified as a risk factor
for active TB disease. After sample exclusions, SNPs were
filtered to remove those that were: non-autosomal (n =
2,355), unmapped in reference genome build 123 (n =
1,225), call-rate <90% (n = 402), minor allele frequency
(MAF) < 0.01 (n = 16,905), and P-value of Hardy-Wein-
berg equilibrium (HWE) test (controls only) < 1 × 10-7 (n
= 110). The resulting post-QC dataset of 108 cases and
115 controls analyzed for 95,207 SNPs was then utilized in
the association study.
Stage 2: validation in Indonesian cohort
Selected from the highest ranking SNP associations from
stage 1, we synthesized 2,453 SNPs (P <0.05) on the Illu-
mina GoldenGate customized array in two separate pools.
As according to manufacturer’s protocol, 1189 indepen-
dent subjects (626 cases and 563 controls) from the same
Indonesian study were genotyped on these GoldenGate
arrays, and the BeadStudio GenCall software was used to
call for genotype [17].
Quality control filtering was based on: sample call-rate
<90% (n = 9), first degree familial relationship (n = 14),
discrepancies with reported gender (n = 11), and history
of diabetes mellitus (n = 15). Following sample exclusions,
SNPs were filtered to remove those that are: unmapped in
reference genome build 123 (n = 3), minor allele frequency
(MAF) <0.01 (n = 44), and P-value for Hardy-Weinberg
equilibrium (HWE) test (controls only) < 1 × 10-7 (n =
25). The resulting post-QC dataset of 600 cases and 540
controls genotyped for 2,381 SNPs was then utilized in the
association analysis.
Assuming a multiplicative model, and a TB prevalence
in Indonesia of 262 cases per 100,000 [1], the total
sample size of the two stage Indonesian cohort has
>80% power to detect associations for risk alleles ≥ 40%
frequency, and OR ≥1.5, for an uncorrected significance
threshold of P = 0.05, which is the nominal alpha we
consider to suggest association [18]. However, to
account for multiple testing a stringent Bonferroni cor-
rected alpha of P = 5.25 × 10-7 (0.05/95,207) is required
to declare genome wide significance in this study.
Stage 3: testing TB association in Russian cohort
Among the top SNP associations detected in the first two
stages involving Indonesian subjects, 251 promising SNPs
(Indonesian 2 stages P < 0.05) were selected for synthesis
in an oligo pool assay (OPA) of the GoldenGate assay, see
Additional file 2, Supplementary Table S1. Genotyping of
these SNPs was performed on 3,760 Russian subjects to
test TB association in a large independent cohort. The
BeadStudio GenCall software was used to call for genotype
[17].
For quality control purpose, 144 subjects were excluded
because of sample duplication, and discrepancies with
reported gender. No other samples were excluded after fil-
tering for call-rate <90%, or of having first-degree familial
relationship. After sample exclusions, SNPs were filtered
to remove those with minor allele frequency (MAF) <0.01
(n = 6), and P-value for Hardy-Weinberg equilibrium
(HWE) tests (controls only) < 1 × 10-7 (n = 2). The result-
ing post-QC dataset of 1,837 cases and 1,779 controls gen-
otyped for 243 SNPs was then utilized in the association
analysis.
Assuming a multiplicative model, and a TB prevalence
in Russia of 150 cases per 100,000 in the population [1],
the overall sample size of the Russian cohort has at least
99% power to detect associations at risk allele ≥ 40% fre-
quency and ORs ≥ 1.5, for an uncorrected significance
threshold of P = 0.05, which is the nominal alpha we con-
sider to suggest association [18].
Analysis of population stratification
Indonesian cohort
As population stratification can confound case-control
association studies [19-21], we performed a principal
components (PC) analysis as implemented in EIGEN-
STRAT to identify and exclude 4 population outliers
within PC1 and 2, from the Indonesian stage 1 dataset,
see Additional file 1, Supplementary Figure S1 [21]. The
median chi-square statistics of the post quality controlled
stage 1 genome wide loci yield a lambda inflation factor
(Devlin and Roeder method) of only 1.003, which indi-
cate that population stratification was minimal in this
study to cause significant inflation to the test statistics,
see Additional file 1, Supplementary Figure S2 [19].
Hence, no further adjustments were made to correct the
association tests for any inflation.
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The marker density of stage 2 was insufficient for per-
forming principal components analysis. Nevertheless, to
avoid spurious genetic associations arising from popula-
tion stratification, efforts were made to ensure subjects
with self-reported ethnicity that were of non-Indonesian
origin were excluded from genotyping. Furthermore, as
described previously, to detect traces of population stratifi-
cation in the Indonesian cohort, a large subset of indivi-
duals (330 cases and 368 controls) that are part of this
study, were genotyped for an independent set of 299
ancestry informative markers. These SNPs were chosen to
be more than 10 Kb away from any known gene, to have
average minor allele frequencies around 30% and to be in
linkage equilibrium with one another [22]. The result of
the lambda inflation factor calculated according to the
method of Devlin and Roeder [19], had a value close to 1,
which further confirmed that there was minimal popula-
tion stratification in this Indonesian cohort [22].
Russian cohort
In order to control for hidden population stratification due
to potential admixture, all Russian subjects were geno-
typed for 15 ancestry-informative markers that was as
reported previously [15]. We selected these markers
among intergenic or intronic SNPs in the non-immune
genes spread across the genome that have minor allele fre-
quency of more than 10% in Europeans and over 65%
difference in allele frequency between European- and
Asian-derived populations [23]. As was reported pre-
viously, all ancestry-informative markers had similar allele
frequency in TB patients and healthy subjects (chi-square
test P > 0.13) thus, suggesting that major adjustments nor
population stratification are likely in this sample [15].
Analysis of relative detection
As cryptic relatedness among study subjects may artifac-
tually inflate the statistics of association in case-control
studies [24], the genotypes of markers that had undergone
quality control (Stage 1 n = 95,207 SNPs, or Stage 2 n =
2,381 SNPs) were used in the Relpair software to find
pairs of individuals who are more similar than expected by
chance in a random sample [25]. Based on the calculated
probabilities, we identified pairs with relationships of an
extent expected for monozygous twins, full siblings, and
parent-offspring. In each instance, the sample with the
higher call-rate was retained in the analysis.
Analysis of association statistics
After sample and SNP quality control, statistics of asso-
ciation were calculated using the PLINK software pack-
age [26]. For detecting associations in the first stage,
Trend tests were performed on 108 cases and 115 con-
trols with genotypes for 95,207 SNPs. Subsequently, for
the combined association results over the entire Indone-
sian cohort, the Cochran-Mantel-Haenszel (CMH) test
was used to perform a stratified analysis across the two
stages for the 2,381 quality filtered SNPs that had been
successfully genotyped in 708 cases and 655 controls. For
the stage 3 sample from Russia, including enrollments
from two cities, the CMH test was used to stratify the
association analysis by city, and provide the test statistics
after controlling for difference in sample location.
Finally, for the combined test statistics across all three
stages of the analysis, the CMH test was performed to
stratify the association analysis by cohort. A stringent Bon-
ferroni corrected alpha of P = 5.25 × 10-7 (0.05/95,207) is
required to declare genome wide significance in this study.
However, due to sample size considerations in this study,
we consider also associations with P-values as low as 0.05
to be suggestive of association.
Results
The demographic characteristics of the participants of our
study are displayed in Table 1. In this study, we tested
SNPs across the genome for association with pulmonary
TB, in three separate stages. First in the discovery phase of
stage 1, following extensive quality control filtering on the
data, we analyzed 95,207 SNPs in 108 cases and 115 con-
trols from Indonesia for association with pulmonary TB
(see Additional file 1, Supplementary Figures S2 and S3).
Among the SNPs tested 4,719 SNPs exceed an uncor-
rected P < 0.05. The median chi-square of this study yields
a genomic control inflation (lGC) of only 1.003, to indicate
that population stratification is minimal to cause signifi-
cant inflation, hence further adjustments were not made
to the test statistics.
In order to validate promising associations from the
initial discovery phase, in the second stage, the validation
phase, we analyzed 2,381 selected top SNPs (Stage 1 P <
0.05) in 708 cases and 655 controls from Indonesia. We
identified 368 SNPs at this stage that were nominally sig-
nificant (P < 0.05) in the combined stage analysis, suggest-
ing association with pulmonary TB in the Indonesian
population.
In order to study TB association in a large independent
cohort, 243 of the above SNPs identified in Indonesia,
were tested in stage 3 in 1,837 cases and 1,779 controls
from Russia. In the combined meta-analysis, 9 SNPs (P =
0.0004-0.0067) were discovered to associate with pulmon-
ary TB, independently across both Indonesian and Russian
cohorts, albeit with nominal (P < 0.05) significance (see
Table 2). These nine SNPs are located within or near the
following genes: JAG1, DYNLRB2, EBF1, TMEFF2, CCL17,
HAUS6, PENK and TXNDC4.
Discussion
Our TB association study extends across two genetically
highly diverse populations. It combines GWAS in Indo-
nesian population and follow-up genotyping of the best
Png et al. BMC Medical Genetics 2012, 13:5
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Table 2 Association results of nine significant SNPs from the combined meta-analysis of all three stages
SNP Chr. Gene Risk
allele
Stage 1
Indo. P*
OR (95% CI) Stage 2
Indo. P*
OR (95% CI) Indo.
allele
freq.
Stage 3
Russ. P*
OR (95% CI) Russ
allele
freq.
Indo. &
Russ. P
OR (95% CI)
rs2273061 20 JAG1 G 0.004 1.80 1.18 2.72 0.01 1.24 1.05 1.46 0.28 0.008 1.14 1.03 1.25 0.43 0.0004 1.16 1.07 1.26
rs4461087 16 DYNLR A 0.009 1.62 1.10 2.37 0.03 1.18 1.01 1.38 0.38 0.01 1.18 1.04 1.34 0.16 0.001 1.18 1.07 1.30
rs10515787 5 EBF1 A 0.006 0.57 0.38 0.88 0.02 0.81 0.68 0.96 0.26 0.02 0.73 0.56 0.96 0.03 0.001 0.79 0.68 0.91
rs10497744 2 TMEFF2 Both SNPs in LD r2
= 0.99 D’ = 1.00
A 0.002 0.55 0.38 0.82 0.02 0.83 0.71 0.97 0.35 0.02 0.89 0.80 0.98 0.30 0.001 0.87 0.80 0.95
rs1020941 2 TMEFF2 C 0.004 0.57 0.38 0.83 0.03 0.84 0.72 0.98 0.35 0.03 0.89 0.81 0.99 0.30 0.002 0.88 0.81 0.95
rs188872 16 CCL17 A 0.004 0.51 0.33 0.78 0.02 0.82 0.70 0.97 0.30 0.04 0.89 0.80 0.99 0.25 0.002 0.87 0.80 0.95
rs10245298 7 HAUS6 A 0.03 2.37 1.09 5.16 0.03 1.40 1.04 1.89 0.07 0.04 1.18 1.01 1.39 0.09 0.005 1.23 1.06 1.41
rs6985962 8 PENK C 0.02 2.01 1.12 3.61 0.04 1.26 1.01 1.59 0.13 0.047 1.14 1.00 1.29 0.15 0.006 1.17 1.05 1.31
rs1418267 9 TXNDC4 A 0.0004 3.19 1.71 5.99 0.04 1.28 1.01 1.62 0.12 0.04 1.11 1.01 1.22 0.40 0.007 1.13 1.03 1.23
Chr.- chromosome, LD- linkage disequilibrium, r2 - R square, D’ - D prime, Indo.- Indonesia, P- P-value, OR- odds ratio, 95%
CI- 95% confidence interval, freq.- frequency, Russ.- Russia
• See Additional file 2, Supplementary Table S2 for genotype counts
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associated SNPs in a large independent cohort from
Russia. Our data provide evidence of possible novel
associations of genetic variants with pulmonary TB sus-
ceptibility. Among them (Table 2), one of our lowest P
values is observed for rs2273061 (P 0.0004, O.R 1.16,
95%C.I. 1.07-1.26), which is in the transcript of JAG1.
This protein is a ligand for the Notch receptor that
plays a central part of the Notch signaling cascade [27].
Mouse macrophages infected with M. bovis BCG have
been shown to up-regulate NOTCH1 signaling leading
to SOCS3 expression via NOTCH1 mediated recruit-
ment of NFB and CSL to the SOCS3 promoter. As
SOCS3 is a critical regulator of cytokine signaling,
induction of this gene by mycobacteria could suggest a
strategy to render infected macrophages unresponsive to
interferon-gamma (IFN-g), which is a central Th1 cyto-
kine [28]. This modulation of host cell signaling
response may be critical for a generalized suppression of
inflammatory responses, and the persistence of myco-
bacteria within the host.
Notch signaling also plays a pivotal role in T cell lineage
commitment, and another associated SNP, rs10515787 (P
0.0013, O.R. 0.79, 95%C.I. 0.68-0.91) is in the EBF1 gene,
which is a central B cell lineage specification factor. In
order for EBF1 to perform its role, it must partner with
PAX5 through a feedback regulation to amplify B cell spe-
cific gene expression and solidify the commitment to the
B cell pathway [29]. PAX5 is the guardian of B cell identity
and functions by down regulating genes that are against B
cell lineage, such as the M-CSF and NOTCH1, which are
required for myeloid development and T cell lineage spe-
cification respectively [30,31]. This counteractive response
of repressing NOTCH1 signaling that is not in favor of T
cell promotion, might suggests an impact on the control
of the intracellular infection of M. tuberculosis.
Two SNPs rs10497744 (P 0.0014, OR 0.87, 95%C.I.
0.80-0.95) and rs1020941 (P 0.0022, OR 0.88, 95%C.I.
0.81-0.95) in LD (r2 = 0.99, D’ = 1.00) that are part of the
associated list are near the TMEFF2 gene. This gene
encodes a transmembrane protein with EGF (epidermal
growth factor)-like and two follistatin-like domains 2,
which is known to contribute to cell proliferation. Shed-
ding of TMEFF2 from the ectodomain is a functionally
important step to release the protein in its active form
for inducing cellular proliferation. This functionally limit-
ing step is highly mediated through an ADAM17 depen-
dent autocrine fashion [32]. Incidentally, ADAM17 also
has a prominent role in activating the cell-fate specifica-
tion Notch signaling pathway, by controlling the shed-
ding of Notch receptor and its ligand JAG1 [33], which is
also our first target gene, mentioned above. An active
ADAM17 regulates EGF receptor expression through
activating NOTCH1 that was demonstrated to affect
proliferation and survival of lung cancer cells, and
tumorigenicity of non-small cell lung cancer [34]. How-
ever, on the other hand, inactivating NOTCH1 or
ADAM17 resulted in substantial cell death, while EGFR
inhibition predominantly induced cell arrest in lung can-
cer [34]. Studies have also shown ADAM17 actively med-
iates the shedding of pro-inflammatory factors in lung
inflammation, and regulate immune cell recruitment and
cytokines secretion that affects the physiology of this
organ [35]. In pulmonary TB, the lung is the primary site
of infection by M. tuberculosis where, responding to inva-
sion, our body reacts by recruiting immune cells and pro-
inflammatory cytokines to attack and control further dis-
semination of a pathogen by forming granuloma, which
may also manifest in tissue damage.
Another example of biologically relevant candidate in
our data is rs188872 (P 0.0023, O.R. 0.87, 95%C.I. 0.80-
0.95), which is near the CCL17 cytokine gene. Lung granu-
lomas in mice were reported to have enhanced CCL17
transcript levels after being stimulated with M. bovis anti-
gen [36]. As a survival mechanism, pathogens such as M.
tuberculosis are known to preferentially shift host cell
response towards Th2 by instigating the production of
Th2 cytokines. When in excess, it would consequently
lead to immuno-suppression that might antagonize the
Th1 mediated microbicidal actions. In natural infection M.
tuberculosis may likely gain from this favorable condition
to survive in infected patients.
Within the Indonesian study, the lowest P value is found
in rs10497225 (P 1.52 × 10-5, O.R. 2.36, 95%C.I. 1.58-3.52),
which is in the SLC4A10 gene, see Additional file 2, Sup-
plementary Table S1. This solute carrier family 4, sodium
bicarbonate transporter, member 10 (SLC4A10) gene is in
a similar class of function as the ion transporter; SLC11A1
(alias NRAMP1), a well studied TB gene involved in iron
metabolism and host resistance to pathogenic mycobac-
teria. Genetic variants of this gene have been associated
with susceptibility to TB and leprosy [37,38]. However, we
could not analyze rs10497225 in the Russian cohort
because this SNP is rare (MAF 0.0007) in this population,
and was excluded after failing MAF filter. In view of this,
we believe some of the association signals could be
affected by possible genetic differences between the host
populations. As these SNPs are merely markers tagging
the actual causal variants based on linkage disequilibrium
(LD), differences in LD patterns and allele frequencies
between differing ethnicities could affect the efficiency of
transferring tags across populations and the power in
detecting associations. This is notwithstanding the fact
that the 100 K SNP GeneChip marker set used in Stage1
is a rather sparse collection of SNPs. The SNPs in this
microarray capture (r2 ≥ 0.8) common variants in the
Asian (JPT+CHB) and European (CEU) genomes at only
30% coverage [39], that are also undersampled in the cod-
ing regions, reducing the level of proxy to genes [40].
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Hence, it is likely that certain regions in the genome are
less adequately tagged with SNPs, which could thereby
have resulted in reduced power for detecting associations.
Although none of the observed association signals
achieved stringent levels of genome wide significance,
likely due to the limited sample size of the Indonesian
GWAS cohort, the major findings from the study of both
Indonesians and Russians does suggest associations at sev-
eral loci, many of which are located in, or close to immune
related genes that have congruous functions toward Th1
axis of the pro-inflammatory IFN-g activity. IFN-g is an
essential cytokine for the effective control of M. tuberculo-
sis in the host, due to its central role in modulating and
bridging both the innate and adaptive immunity, impair-
ments in this axis of cytokine activity could render adverse
consequences. A previous study conducted on a subset of
samples from the same Indonesian cohort, had peripheral
blood cells taken from active TB patients, patients under-
going treatment, and healthy controls, and traced for Th1
cytokines production in response to M. tuberculosis and
mitogen stimulations [12]. The integrity of major pathways
involved in Th1 immunity were analyzed, among them
IFN-g level was found to be significantly correlated with
TB disease activity and response to curative treatment,
that was specific to M. tuberculosis stimulation [12]. This
change in cytokine activity according to the disease course
of pulmonary TB is unlikely due to major defects in IFN-g
itself, since mutations in this molecule and its receptors
are known to implicate rare severe infections to otherwise
poorly pathogenic mycobacteria [41,42]. Rather, in pul-
monary TB, a complex disease with adult onset, it is more
likely due to the accumulation of individual subtle effects
from variations in genes, such as those suggested from this
study that are working together in similar pathways, which
might sway the immune responses of the group of suscep-
tible individuals toward active disease.
Conclusions
Tuberculosis is a complex disease resulting from multi-
ple contributing factors, and the mechanism that trig-
gers active disease is unlikely to be simplistic. Aiming to
expand TB disease knowledge, this study took a com-
prehensive search across the genome, and suggests mul-
tiple targets working in novel pathways involved in the
host containment of infection with TB, further providing
insights on the mechanism of this disease, that could
previously be neglected in hypothesis driven approach.
Additional material
Additional file 1: Supplementary Figure S1: Principal component
ancestry (PCA) analysis plots of the stage 1 Indonesian GWAS cohort.
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